Are Wall Street Analysts Predicting Stryker Stock Will Climb or Sink?

Valued at a market cap of $127.1 billion, Stryker Corporation (SYK) is a global medical technology company that develops and sells a broad range of products designed to improve surgical procedures and patient outcomes. The Michigan-based company’s portfolio spans MedSurg and Neurotechnology, including surgical equipment, endoscopy systems, patient-handling solutions, emergency-care products, neurovascular devices, and neurosurgical technologies, as well as Orthopaedics, covering joint replacement implants, trauma and extremities products, and robotic-assisted surgical technologies such as Mako.

Stryker stock has been stuck in the recovery room while the broader market keeps running laps. SYK has declined 12.8% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 20.2%. The gap has persisted in 2026, with SYK slipping 3.3% YTD even as the broader index has climbed 12.6%.